Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial
Authors
Sen Wei (ORCID: https://orcid.org/0000-0002-1831-6818)
Shaohan Yin
Yi Hu (ORCID: https://orcid.org/0000-0002-1408-9531)
Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial
Sen Wei, Shaohan Yin, Yi Hu, ShiYang Zheng et al.
Citations
5 citations
Journal
EClinicalMedicine
Topics
Esophageal Cancer Research and Treatment
Field-Weighted Citation Impact (FWCI)
10.03
article
Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial
Sen Wei, Shaohan Yin, Yi Hu, ShiYang Zheng, YuMing Rong, FangJie Liu, Chuanmiao Xie, Bo Qiu, Y. Situ, PengXin Zhang, Mengru Wang, DaQuan Wang, Hao Zhang, Hui Liu
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
EClinicalMedicineVol. 82
Institutions
Sun Yat-sen University (CN), Gansu Provincial Hospital (CN), Sun Yat-sen University Cancer Center (CN)